Get started for just $50 for your first month
Similar content being viewed by others Main Dual agonism of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors (GLP-1R and GIPR, respectively), in the form of once-weekly injectable tirzepatide, is highly effective for treating people living with obesity and type 2 diabetes, resulting in greater weight loss than GLP-1R agonism alone 2
This weekly injection slows digestion, reduces appetite, and improves blood sugar control
The core mediators of the immune system, the lymphocytes, perform their bacterial, viral and cancer cell killing function by generating large amounts of ROS, including superoxide and hydrogen peroxide
DUI school for 3 to 36 months